Literature DB >> 28325177

Equine Cardiovascular Therapeutics.

Meg M Sleeper1.   

Abstract

Heart disease can be defined as any abnormality of the heart whether it is a cardiac dysrhythmia or structural heart disease, either congenital or acquired. Heart failure occurs when a cardiac abnormality results in the inability of the heart to pump enough blood to meet the body's needs. Heart disease can be present without leading to heart failure. Heart failure, however, is a consequence of heart disease. There are 4 main areas where the clinician can intervene to improve cardiac output with heart failure: preload, afterload, myocardial contractility, and heart rate.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiarrhythmic; Atrial fibrillation; Congestive heart failure; Dysrhythmia; Valve disease

Mesh:

Year:  2017        PMID: 28325177     DOI: 10.1016/j.cveq.2016.11.005

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  2 in total

1.  Equine glucagon-like peptide-1 receptor physiology.

Authors:  Murad H Kheder; Simon R Bailey; Kevin J Dudley; Martin N Sillence; Melody A de Laat
Journal:  PeerJ       Date:  2018-01-29       Impact factor: 2.984

2.  Pharmacokinetic and pharmacodynamic properties of orally administered torsemide in healthy horses.

Authors:  Gustavo F Agne; Seung Woo Jung; Anne A Wooldridge; Susan H Duran; William Ravis; Ramiro Toribio
Journal:  J Vet Intern Med       Date:  2018-05-17       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.